» Articles » PMID: 324398

Therapy of Antimicrobial-resistant Typhoid Fever

Overview
Specialty Pharmacology
Date 1977 Apr 1
PMID 324398
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Antimicrobial-resistant typhoid fever in Saigon was studied by examining in vitro antimicrobial susceptibilities of Salmonella typhi strains and conducting a randomized clinical trial of ampicillin and trimethoprim-sulfamethoxazole (TMP-SMZ). Isolates of S. typhi were obtained from blood or stool cultures of 90 patients. Of 87 isolates tested for antimicrobial susceptibility, 65 (75%) were resistant (R) to chloramphenicol, streptomycin, sulfonamide, and tetracycline, and 22 (25%) were susceptible (S). The drug resistance was transferable to Escherichia coli and was found in 11 different Vi-phage types. All isolates were susceptible to ampicillin and to TMP-SMZ. Agar dilution studies of TMP and SMZ showed synergistic inhibition of growth in all 18 S isolates and in 12 of 48 R isolates tested. The clinical trial of ampicillin and TMP-SMZ showed that both drugs were equally effective. Treatment failure with both drugs was more frequent in patients with S isolates than in patients with R isolates. Therefore, in an area where antimicrobial-resistant typhoid fever exists, patients with R isolates should receive either ampicillin or TMP-SMZ, but patients with S isolates should be treated with chloramphenicol.

Citing Articles

Epidemiology, Clinical Presentation, Laboratory Diagnosis, Antimicrobial Resistance, and Antimicrobial Management of Invasive Salmonella Infections.

Crump J, Sjolund-Karlsson M, Gordon M, Parry C Clin Microbiol Rev. 2015; 28(4):901-37.

PMID: 26180063 PMC: 4503790. DOI: 10.1128/CMR.00002-15.


Comparison of ofloxacin and ceftriaxone for short-course treatment of enteric fever.

Smith M, Duong N, Hoa N, Wain J, Ha H, Diep T Antimicrob Agents Chemother. 1994; 38(8):1716-20.

PMID: 7986000 PMC: 284627. DOI: 10.1128/AAC.38.8.1716.


Cefamandole treatment of Salmonella bacteremia.

de Carvalho E, Martinelli R, de Oliveira M, Rocha H Antimicrob Agents Chemother. 1982; 21(2):334-5.

PMID: 7073269 PMC: 181882. DOI: 10.1128/AAC.21.2.334.


Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.

Wormser G, Keusch G, Heel R Drugs. 1982; 24(6):459-518.

PMID: 6759092 DOI: 10.2165/00003495-198224060-00002.


Treatment of experimental Salmonella typhimurium infection with mecillinam and ampicillin.

Butler T, SHUSTER C, Dixon P Antimicrob Agents Chemother. 1981; 19(2):328-31.

PMID: 6289730 PMC: 181421. DOI: 10.1128/AAC.19.2.328.


References
1.
Sardesai H, Karandikar R, Harshe R . Comparative trial of Co-trimoxazole and Chloramphenicol in Typhoid Fever. Br Med J. 2010; 1(5845):82-3. PMC: 1588757. DOI: 10.1136/bmj.1.5845.82. View

2.
WOODWARD T, SMADEL J . MANAGEMENT OF TYPHOID FEVER AND ITS COMPLICATIONS. Ann Intern Med. 1964; 60:144-57. DOI: 10.7326/0003-4819-60-1-144. View

3.
AKINKUGBE O, Lewis E, Montefiore D, Okubadejo O . Trimethoprim and sulphamethoxazole in typhoid. Br Med J. 1968; 3(5620):721-2. PMC: 1989616. DOI: 10.1136/bmj.3.5620.721. View

4.
BAUER A, KIRBY W, SHERRIS J, Turck M . Antibiotic susceptibility testing by a standardized single disk method. Am J Clin Pathol. 1966; 45(4):493-6. View

5.
Kaye D, Eyckmans L, Rocha H, Prata A, Hook E . Comparison of parenteral ampicillin and parenteral chloramphenicol in the treatment of typhoid fever. Ann N Y Acad Sci. 1967; 145(2):423-8. DOI: 10.1111/j.1749-6632.1967.tb50241.x. View